$375 Million is the total value of Newtyn Management, LLC's 37 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | JACKSON FINANCIAL INC | $22,818,000 | – | 877,600 | +100.0% | 6.09% | – | |
| BAMR | New | BROOKFIELD ASSET MGMT REINScl a exch lt vtg | $12,501,000 | – | 225,000 | +100.0% | 3.33% | – |
| New | INFLECTION POINT ACQUSTN CORunit 09/21/2026 | $9,880,000 | – | 1,000,000 | +100.0% | 2.64% | – | |
| CIO | New | CITY OFFICE REIT INC | $9,355,000 | – | 523,781 | +100.0% | 2.50% | – |
| ODP | New | THE ODP CORP | $8,032,000 | – | 200,000 | +100.0% | 2.14% | – |
| SATS | New | ECHOSTAR CORPcl a | $7,653,000 | – | 300,000 | +100.0% | 2.04% | – |
| DXLG | New | DESTINATION XL GROUP INC | $6,732,000 | – | 1,100,000 | +100.0% | 1.80% | – |
| New | BLUE FOUNDRY BANCORP | $2,604,000 | – | 188,816 | +100.0% | 0.70% | – | |
| LEGO | New | LEGATO MERGER CORP | $1,247,000 | – | 118,550 | +100.0% | 0.33% | – |
| TBPH | New | THERAVANCE BIOPHARMA INC | $725,000 | – | 97,955 | +100.0% | 0.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIRIT AEROSYSTEMS HLDGS INC | 33 | Q2 2021 | 24.0% |
| NI HLDGS INC | 27 | Q3 2023 | 2.9% |
| ADIENT PLC | 26 | Q1 2023 | 17.3% |
| MERRIMACK PHARMACEUTICALS IN | 25 | Q3 2023 | 5.7% |
| PG&E CORP | 24 | Q3 2023 | 19.2% |
| SPECTRUM BRANDS HLDGS INC NE | 21 | Q3 2023 | 6.7% |
| RAFAEL HLDGS INC | 18 | Q2 2022 | 7.4% |
| CUSTOMERS BANCORP INC | 18 | Q1 2023 | 3.7% |
| BRISTOW GROUP INC | 14 | Q3 2023 | 4.8% |
| APPLIED OPTOELECTRONICS INC | 14 | Q3 2021 | 2.2% |
View Newtyn Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PFSWEB INC | February 14, 2023 | 1,206,502 | 5.3% |
| Garrett Motion Inc. | February 14, 2022 | 1,571,451 | 2.4% |
| Flexion Therapeutics Inc | November 24, 2021 | 4,400,000 | 8.7% |
| FLOTEK INDUSTRIES INC/CN/ | February 16, 2021 | 2,789,059 | 3.8% |
| Forward Pharma A/SSold out | February 16, 2021 | 0 | 0.0% |
| Pfenex Inc. | October 02, 2020 | 650,000 | 1.9% |
| CymaBay Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
| Recro Pharma, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
| Stable Road Acquisition Corp. | February 14, 2020 | 700,000 | 3.9% |
| CSW INDUSTRIALS, INC. | February 14, 2017 | 330,000 | 2.1% |
View Newtyn Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-03-08 |
| SC 13D/A | 2024-03-07 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2024-02-13 |
| SC 13D/A | 2024-01-25 |
View Newtyn Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.